Literature DB >> 24591532

Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?

Giovanni Di Maggio1, Roberto Santangelo1, Simone Guerrieri1, Mariangela Bianco1, Laura Ferrari1, Stefania Medaglini1, Mariaemma Rodegher1, Bruno Colombo1, Lucia Moiola1, Raffaella Chieffo1, Ubaldo Del Carro1, Vittorio Martinelli1, Giancarlo Comi1, Letizia Leocani2.   

Abstract

OBJECTIVE: To assess the sensitivity of optic coherence tomography (OCT) and visual evoked potentials (VEPs) to visual pathway abnormalities in multiple sclerosis (MS).
METHODS: A total of 40 MS subjects, 28 with optic neuritis (ON) at least 3 months before (bilateral in 5), underwent assessment of visual acuity, Expanded Disability Status Scale (EDSS), OCT and VEPs, the latter quantified with a 0-4 conventional score.
RESULTS: OCT and VEPs were abnormal in 36% and 56% respectively in all eyes (p=0.11), 68% and 86% in eyes with previous ON (p=0.12), and in 19% versus 40% in eyes without ON history (p=0.007). Combining VEP and OCT increased sensitivity to 89% in ON and 44% in non-ON eyes. Considering all eyes, global retinal nerve fibre layer (RNFL) thickness and VEP score were significantly correlated between them (ρ=-0.63, p<0.001) and with EDSS (RNFL: ρ=0.40, p<0.001; VEP score: ρ=0.47, p<0.001). Disease duration correlated with VEP score (ρ=0.25, p=0.025) and RNFL thickness (ρ=-0.71, p<0.001).
CONCLUSIONS: In eyes without ON, VEPs were more frequently abnormal than OCT, while the two techniques showed similar sensitivity in eyes previously affected by ON. The correlation of VEPs and OCT measures with disability prompts further exploration of the two techniques as potential markers of disease burden.
© The Author(s) 2014.

Entities:  

Keywords:  Multiple sclerosis; disability; optic coherence tomography; optic neuritis; spectral domain; visual evoked potentials

Mesh:

Year:  2014        PMID: 24591532     DOI: 10.1177/1352458514524293

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

1.  Evoked potentials as a biomarker of remyelination.

Authors:  Moones Heidari; Abigail B Radcliff; Gillian J McLellan; James N Ver Hoeve; Kore Chan; Julie A Kiland; Nicholas S Keuler; Benjamin K August; Dylan Sebo; Aaron S Field; Ian D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

2.  Functional-structural assessment of the optic pathways in patients with optic neuritis.

Authors:  Mathias Falck Schmidt; Gorm Pihl-Jensen; Jette Lautrup Frederiksen
Journal:  Doc Ophthalmol       Date:  2019-10-17       Impact factor: 2.379

3.  Relationship between optical coherence tomography angiography and visual evoked potential in patients with multiple sclerosis.

Authors:  Sedat Ava; Yusuf Tamam; Leyla Hazar; Mine Karahan; Seyfettin Erdem; Mehmet Emin Dursun; Ugur Keklikçi
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

4.  Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.

Authors:  Mona Laible; Sven Jarius; Friedericke Mackensen; Annette Schmidt-Bacher; Michael Platten; Jürgen Haas; Philipp Albrecht; Brigitte Wildemann
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

Review 5.  A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.

Authors:  Martin Hardmeier; Letizia Leocani; Peter Fuhr
Journal:  Mult Scler       Date:  2017-05-08       Impact factor: 6.312

6.  Optical coherence tomography and visual evoked potentials in pediatric MS.

Authors:  Amy T Waldman; Grant T Liu; Amy M Lavery; Geraldine Liu; William Gaetz; Tomas S Aleman; Brenda L Banwell
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-06-05

7.  Optical Coherence Tomography versus Visual Evoked Potentials for Detecting Visual Pathway Abnormalities in Patients with Neuromyelitis Optica Spectrum Disorder.

Authors:  Nam Hee Kim; Ho Jin Kim; Cheol Yong Park; Kyoung Sook Jeong; Joong Yang Cho
Journal:  J Clin Neurol       Date:  2018-02-28       Impact factor: 3.077

8.  Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.

Authors:  Rachel C Nolan; Steven L Galetta; Teresa C Frohman; Elliot M Frohman; Peter A Calabresi; Carmen Castrillo-Viguera; Diego Cadavid; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2018-12       Impact factor: 3.042

Review 9.  Acute optic neuritis: Unmet clinical needs and model for new therapies.

Authors:  Steven L Galetta; Pablo Villoslada; Netta Levin; Kenneth Shindler; Hiroshi Ishikawa; Edward Parr; Diego Cadavid; Laura J Balcer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-07-23

10.  Objective assessment of a relative afferent pupillary defect by B-mode ultrasound.

Authors:  Felix A Schmidt; Florian Connolly; Matthew B Maas; Ulrike Grittner; Lutz Harms; Alexander Brandt; Friedemann Paul; Stephan Schreiber; Klemens Ruprecht
Journal:  PLoS One       Date:  2018-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.